Safety biomarkers are essential for various reasons:
Early Detection: They enable the early detection of potential adverse drug reactions (ADRs), which can prevent serious health complications. Risk Assessment: They help in the assessment of the risk associated with drug candidates during the drug development process. Regulatory Compliance: Regulatory agencies like the FDA and EMA require the use of validated safety biomarkers for the approval of new drugs. Patient Safety: They contribute to personalized medicine by ensuring that patients receive safe and effective treatment based on their unique biomarker profiles.
